Solventum Corporation

NYSE:SOLV

Medical - Care Facilities

Healthcare
$86.48 -2.61%

-$2.00 today

Market cap
$14.70B
Beta
0.75
P/E (TTM)
9.1
EPS (TTM)
$8.22
52W Low $62.38High $88.20

Volume 0.76M

Average 1.70M

SOLV Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Solventum CorporationNYSE: SOLV

Financing Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Financing cash flow grows, but more slowly than its trailing trend

Q2 FY2026 financing cash flow of $300M (cash outflow) rose 172.7% year over year, behind the +469.0% change in trailing-twelve-month financing cash flow. Sequentially, it rose 500.0% from the prior quarter. Over 3 fiscal years it compounded at +27.9% a year.

Context

  • Financing cash flow amounted to 36.7% of revenue in FY2025, up 33.8 pp from a year earlier.
  • Financing cash flow grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +172.7% toward the trailing-twelve-month pace of +469.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$300M+500.0% QoQ
Last fiscal yearDec 2025
-$3.06B+1173.8% YoY
LTMJun 2026
-$3.16B+469.0% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+172.7%——
1 year+1173.8%——
3-year CAGR+27.9%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
(3.06B) USD
Year-over-year change
-1173.8%

Financing Cash Flow vs competitors

How SOLV compares with its peers on the latest reported figures

  • SOLV's LTM Jun 2026 financing cash flow of $3.16B is the largest of the 10 companies compared; the peer median is $270M.
  • Its year-over-year change of +469.0% is the 2nd highest of 10, against a peer median of -42.7%.
  • Financing cash flow amounts to 38.0% of revenue for SOLV, versus a peer median of 7.2%.
SOLV Competitors Peer median
Financing Cash Flow for SOLV and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SOLVSolventum CorporationLTM Jun 2026$3.16B +469.0%+27.9%38.0%
BDXBecton, Dickinson and CompanyLTM Sep 2026$2.24B -38.1%+3.4%11.1%
COOThe Cooper Companies, Inc.LTM Jul 2026$641M +121.1%—15.1%
HSICHenry Schein, Inc.LTM Jun 2026$381M +632.7%-29.4%2.8%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026$322M +95.2%-37.6%8.7%
BAXBaxter International Inc.LTM Jun 2026$270M -93.2%+43.1%2.4%
ICUIICU Medical, Inc.LTM Jun 2026$154.53M -42.7%—7.2%
NVSTEnvista Holdings CorpLTM Oct 2026$25.2M -82.8%—0.9%
UTMDUtah Medical Products, Inc.LTM Mar 2026$9.22M -61.7%+31.0%24.6%
MMSIMerit Medical Systems, Inc.LTM Sep 2026$5.06M -62.1%—0.3%
Peer median (excluding SOLV) $270M-42.7%+3.4%7.2%

Competitors are the stored peer set for SOLV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income1.46B1.34B1.35B479M1.56B
Depreciation & Amortization597M578M561M555M489M
Deferred Income Tax(34M)(141M)(142M)(155M)(120M)
Stock-Based Compensation38M37M39M112M161M
Change in Working Capital67M(202M)126M160M(119M)
Accounts Receivables(1M)(32M)(129M)276M78M
Inventory(136M)(82M)23M(132M)(139M)
Accounts Payables68M25M105M266M104M
Other Working Capital136M(113M)127M(250M)(162M)
Other Non-Cash Items74M64M(15M)34M(1.6B)
Operating Cash Flow2.2B1.68B1.92B1.19B369M
Capital Expenditures(277M)(251M)(290M)(380M)(379M)
Acquisitions (Net)0060M0(696M)
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(1M)(2M)003.87B
Investing Cash Flow(278M)(253M)(230M)(380M)2.8B
Debt Repayment0008B(3.07B)
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.96B)(1.46B)(1.55B)(8.24B)13M
Financing Cash Flow(1.96B)(1.46B)(1.55B)(240M)(3.06B)
Effect of Forex Changes3M4M03M7M
Net Change in Cash(33M)(30M)133M568M116M
Free Cash Flow1.93B1.43B1.63B805M(10M)

Solventum Corporation

NYSE:SOLV

Intrinsic Alpha fair value

Locked

Current Price

$86.48

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.